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Adenoassociated virus (AAV) provirus in latently infected cells is rescued by superinfection with adenovirus. We examined
helper-independent rescue of AAV by Fas-mediated apoptosis from the HeLa lines with AAV DNA integrated in chromosome
(HeLa/AAV). In HeLa/AAV, anti-Fas antibody was found to induce low-level production of AAV virions, as detected by the
presence of AAV DNA protected from DNase digestion. The antibody induced higher virion production in Fas-enriched
HeLa/AAV, which was generated by transfecting HeLa/AAV with an expression plasmid for Fas, than in HeLa/AAV, and the
rescued virions were shown to be infectious as assayed along with adenovirus. The antibody also induced apoptotic DNA
fragmentation, as detected by staining intracellular fragmented DNA and electrophoresis, in HeLa/AAV and, more markedly,
in Fas-enriched HeLa/AAV. Furthermore, an inhibitor for caspase-8 suppressed both the AAV virion production and the DNA
fragmentation. Thus, the integrated AAV DNA is likely to be induced to initiate a low level of replication when Fas-mediatedINTRODUCTION
Adenoassociated virus (AAV) type 2, a human par-
vovirus, is a nonenveloped small virus with a genome
of 4.7-kb single-stranded linear DNA (Berns and Bo-
henzky, 1987; Srivastava et al., 1983). Optimal propa-
gation of AAV requires coinfection with a helper virus,
such as adenovirus (Carter et al., 1979; Richardson
and Westphal, 1981; West et al., 1987), herpes simplex
virus (Buller et al., 1981; Mishra and Rose, 1990; Wein-
dler and Heilbronn, 1991), and human cytomegalovirus
(Georg-Fries et al., 1984; McPherson et al., 1985).
Without a helper virus the AAV genome is integrated
into the host chromosomal DNA in a site-specific man-
ner and is maintained as a latent provirus (Berns and
Giraud, 1996). When a latently infected cell is super-
infected with a helper virus, the integrated AAV is
induced to replicate (Handa et al., 1977; Cheung et al.,
1980). A low level of AAV replication is induced by
irradiation of the latently infected cells with UV (Yalki-
noglu et al., 1988), or exposure of cells with genotoxic
chemical carcinogens prior to infection with AAV (Ya-
kobson et al., 1987).
Apoptosis is the programmed cell death that occurs
through multiple pathways (Nagata, 1997). In Fas-me-
diated apoptosis, Fas-ligand’s binding to Fas (a mem-
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90ber of the TNF receptor family or a type I-membrane
protein) at the cell surface initiates a series of molec-
ular events leading to cell death (Itoh et al., 1991; Suda
et al., 1993; Itoh and Nagata, 1993; Nagata and Gol-
stein, 1995). The binding induces trimerization of Fas,
and its trimerized cytoplasmic region sends apoptosis
signals. After the trimerization, the recruited and acti-
vated caspase-8 triggers the ICE protease cascade
(Boldin et al., 1996; Nagata, 1997) and finally activates
caspase-3, resulting in activation of DNase (CAD),
which digests chromosomal DNA into fragments
(Enari et al., 1998; Tang and Kidd, 1998; Inohara et al.,
1999; McIlroy et al., 1999). Without Fas-ligand, the
apoptosis can also be induced by cross-linking of Fas
with agonistic anti-Fas antibodies (Alnemri et al.,
1996).
In this study, to test the hypothesis that AAV provirus
has a system to escape from host cells dying of apo-
ptosis, we examined the rescue of AAV by Fas-medi-
ated apoptosis, using two newly established HeLa cell
lines with AAV DNA in their chromosomes. It was
found that anti-Fas antibody caused both production of
infectious AAV virions and apoptotic DNA fragmenta-
tion in the HeLa cells. An inhibitor for caspase-8,
which suppressed the DNA fragmentation, completely
inhibited the rescue of the AAV. The results show that,
from the AAV DNA integrated in the human chromo-
some, a low level of AAV replication can occur in theapoptosis is activated in HeLa cells. © 2002 Elsevier Science (
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RESULTS AND DISCUSSION
HeLa cells with AAV DNA integrated in chromosome
(HeLa/AAV)
To test our hypothesis, we attempted to prepare HeLa
cell clones that contain the complete AAV genome inte-
grated in cell chromosome (HeLa/AAV). HeLa cells were
transfected with pUC19-AAV (7.1 kilobase pairs (kb long)
that had been linearized by digestion with ScaI cleaving
pUC19 sequence at a single site, together with an ex-
pression plasmid for selectable blasticidin-resistant
gene, pSV-bls. One hundred three clones of blasticidin-
resistant HeLa were obtained and examined for the pres-
ence of AAV DNA in the cellular DNA by agarose gel
electrophoresis after amplification of DNA fragments en-
coding viral capsid proteins (VP-1 to -3) by PCR. Ten
clones positive for the DNA fragment were selected and
were further screened for the presence of rescuable AAV
DNA in them. The cells were inoculated with adenovirus
type 2 (Ad) at a multiplicity of infection (m.o.i.) of 100, and
at 48 h after infection levels of AAV DNA were measured
by semiquantitative PCR with the supernatant fraction of
the modified Hirt’s extraction (Arad, 1998), which presum-
ably contains AAV virion DNA. Two clones that produced
the highest level of AAV DNA, HeLa/AAV-53 and -107,
were selected for further characterization regarding pro-
duction of infectious virions and state of viral DNA in the
cells.
HeLa/AAV-53 or -107 was found to produce infectious
AAV virions after infection with Ad. HeLa/AAV-53 or -107
(5  106 cells) in a 10-cm plate was infected with Ad at
an m.o.i. of 30 and incubated for 72 h. Cells were har-
vested, resuspended with 1 ml of PBS, freeze-thawed
five times, incubated at 60°C for 30 min to inactivate Ad,
and then centrifuged at 15,000 g for 5 min to obtain the
supernatant. Fresh HeLa cells were inoculated with the
supernatant, which was digested with DNase to elimi-
nate free-DNA, together with fresh Ad. Forty-eight hours
later, presence of AAV capsid proteins in cell lysate was
examined by immunoblotting (Fig. 1A). AAV capsid pro-
teins were expressed in HeLa cells inoculated with the
supernatant, indicating that the supernatant contained
infectious AAV. Furthermore, AAV virions, icosahedral
particles with a diameter of 20 nm, was found in the
supernatant by electron microscopy (data not present-
ed). Thus, it was concluded that, similar to the cells
latently infected with AAV, HeLa/AAV-53 and -107 con-
tained complete AAV DNA that can be rescued by Ad
infection.
HeLa/AAV-53 and -107 were examined for the state of
AAV DNA by Southern blotting using total cellular DNA
and the probe for AAV DNA (Fig. 2). The DNA samples
not digested with any restriction enzymes showed the
signals near the top of the separating gel, indicating that
AAV DNA migrated with high molecular weight cellular
DNA (Fig. 2A). Signals for DNA with a size of free AAV
DNA or pUC19-AAV were not detected even after pro-
longed exposure (data not presented). Therefore, these
results suggest that, in HeLa/AAV-53 and -107, AAV DNA
is integrated within cell DNA.
Cleavage with XbaI, which does not cut double-
stranded AAV DNA and pUC19-AAV, gave rise to a broad
and intense signal band in HeLa/AAV-53 DNA and a
clear single band in HeLa/AAV-107 DNA (Fig. 2B). These
DNA fragments were 11-kb long, which were longer than
AAV DNA (4.7 kb) or pUC19-AAV. The intensity of the
band in HeLa/AAV-53 DNA suggests that this band con-
tained a mixture of two to three copies of AAV DNA
flanked by nonviral sequences. When the membrane
blotted with the XbaI-digested DNA samples was re-
probed with the AAVSI BamHI segment (Lamartina et al.,
FIG. 1. Detection of AAV capsid proteins and Fas by immunoblotting.
(A) AAV capsid proteins, VP-1 to -3, expressed in HeLa inoculated with
AAV virions rescued by Ad superinfection. HeLa cells were inoculated
with lysates from Ad-infected HeLa/AAV-53 and -107, together with Ad.
Cellular lysate obtained 48 h later was electrophoresed in a 10%
polyacrylamide gel and the proteins were transferred to a nylon mem-
brane. Capsid proteins were detected with anti-AAV capsid antibody.
(B) Detection of Fas overexpressed in HeLa/AAV/Fas-1 and Fas-2.
Cellular lysates were analyzed by immunoblotting with anti-Fas anti-
serum. (C) AAV capsid proteins expressed in HeLa/AAV clones after Ad
infection. The cells were infected with Ad at an m.o.i. of 50. Cellular
lysates were obtained at 48 h (HeLa and HeLa/AAV-53) or at 72 h
(HeLa/AAV/Fas-1 and -2) postinfection and analyzed by immunoblotting
with anti-AAV capsid antibody. Lines 53 and 107 represent HeLa/AAV
clones and Fas-1 and Fas-2 represent HeLa/AAV/Fas clones.
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2000), the probe hybridized with a DNA fragment differ-
ent from the 11-kb DNA (data not shown), which indicate
that, in HeLa/AAV-53 and -107 cells, AAV DNA was not
integrated in the AAVS1 region.
Cleavage with HindIII, which cleaves AAV DNA once
(also cut pUC19-AAV once), generated four and two
bands, respectively (Fig. 2C). Interestingly, bands of 6.5
and 2.0 kb were found in both HeLa/AAV-53 and -107
DNA and were more intense in HeLa/AAV-53 than in -107.
Cleavage with another one-cut enzyme, BamHI (also
one-cut for pUC19-AAV), resulted in three bands in HeLa/
AAV-53 and in two bands in HeLa/AAV-107. The bands of
5.4 and 3.9 kb were also found in both HeLa/AAV-53 and
-107 DNAs and were more intense in HeLa/AAV-53 than
in -107 (Fig. 2C). When the membrane blotted with
HindIII- or BamHI-cleaved DNA samples was rehybrid-
ized with the probe for pUC DNA, the bands were found
at the same positions for those generated by the AAV-
probe (data not shown). These results, along with the
data obtained with the undigested DNA (Fig. 2A) and
XbaI-digested samples (Fig. 2B), indicate that the AAV
DNA flanked by pUC sequences is integrated, possibly
at a similar site in cell DNA, in HeLa/AAV-53 and -107.
The integrated AAV DNA appeared to be released from
high molecular weight cellular DNA by digestion with
BglII, which can excise AAV DNA from pUC19-AAV (Fig.
2D). The digestion generated a 4.7-kb band correspond-
ing to the complete AAV DNA with both HeLa/AAV-53 and
-107 DNA, and with the former an additional less dense
4.2-kb band. Also, electrophoresed together for compar-
ison were BglII-digested mixtures of pUC19-AAV and
normal HeLa DNA (corresponding to one, two, and four
copies of double-stranded AAV DNA per cell). Compari-
son of the intensities of the 4.7-kb bands indicates that
HeLa/AAV-53 and -107 are likely to have two and one
copies of complete AAV DNA, respectively. HeLa/AAV-53
appears to have one copy of 4.2-kb incomplete AAV DNA,
probably lacking BamHI site and thus yielding 7.7-kb
band after the digestion (Fig. 2C). In HeLa/AAV-53 dupli-
cation of the area around the integrated AAV may have
occurred after the integration.
Although they were morphologically indistinguishable
from the parental HeLa cells, two clones HeLa/AAV-53
and -107, which were shown to have the integrated AAV
DNA that can be rescued by Ad superinfection, showed
slightly reduced growth rate and lowered saturation den-
sities as reported previously for HeLa cells latently in-
fected with AAV (Walz and Schlehofer, 1998).
Production of AAV virion by anti-Fas antibody in
HeLa/AAV
After exposure of HeLa/AAV-53 and -107 to anti-Fas
antibody, AAV virions emerged in the cell extracts, as
detected as AAV DNA that was protected from digestion
with DNase (Fig. 3). An extract from the cells (2  105)
FIG. 2. Southern blotting analyses of restriction DNA fragments from HeLa/AAV and HeLa/AAV/Fas. Total cellular DNA was extracted from the cells
indicated. Eighteen micrograms of DNA, undigested or digested by restriction enzymes, was electrophoresed through a 0.8% agarose gel and
immobilized on a nylon membrane. (A) Undigested DNA. (B) DNA cleaved with XbaI (no cut enzyme for double-stranded AAV DNA and pUC19-AAV).
(C) DNA cleaved with HindIII or BamHI (one cut enzymes). (D) DNA cleaved with BglII, which release AAV DNA from pUC19-AAV. For comparison,
BglII-digested pUC19-AAV, which corresponded to one, two, and four genome copies of double-stranded form per cell, was electrophoresed in the
presence of BglII-digested normal HeLa DNA. Probes were prepared by labeling of AAV DNA with 32P by random primer labeling kit (Rediprime II DNA
labeling system; Amersham Pharmacia Biotech). The double-stranded AAV DNA is indicated by an asterisk. Lines 53 and 107 represent HeLa/AAV
clones and Fas-1 and Fas-2 represent HeLa/AAV/Fas clones.
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which were cultured for 48 h with medium containing
anti-Fas antibody (100 ng/ml) was digested with DNase,
and then DNA for PCR to amplify AAV DNA was ex-
tracted. When the mixture of 107 genome copies of
cloned AAV DNA and cellular DNA extracted from 2 
106 of normal HeLa cells were digested under the con-
ditions used in this experiment, AAV DNA and cellular
DNA encoding G3PDH gene were not amplified by the
PCR (Fig. 3). When AAV virions more than 104 genome
copies were used instead of the cloned AAV DNA, the
AAV DNA fragment was amplified by the PCR, indicating
that DNA in virions were protected against the DNase
digestion (Fig. 3). The levels of the amplified DNA frag-
ment were parallel with those of input virions (Fig. 2). The
results show that AAV DNA protected from DNase diges-
tion was encapsidated in virions. Thus, stimulation with
anti-Fas antibody appeared to induce replication of inte-
grated AAV DNA in HeLa cells. Response to anti-Fas
antibody was more prominent in HeLa/AAV-53 than in
-107. An attempt to stimulate the cells with antibody
against FLAG (a polypeptide unrelated to Fas) did not
induce the replication (Fig. 3). Approximately 104 to 105
virions or genome copies of the encapsidated AAV DNA
were present in the extract from 2  105 cells from
HeLa/AAV-53 or -107 that had been cultured in the pres-
ence of anti-Fas antibody.
Induction of AAV production by anti-Fas antibody in
HeLa/AAV enriched with Fas (HeLa/AAV/Fas)
To test whether the AAV production depends on the
level of Fas on the cell surface, we prepared HeLa/AAV
enriched with Fas (HeLa/AAV/Fas) and examined its re-
sponse to the antibody regarding AAV virion production.
HeLa/AAV-53 was transfected with the newly con-
structed expression plasmid for Fas, pCMV-Fas, which
contains an expression unit for G418-resistant gene. Im-
munoblotting using anti-Fas antibody showed that, while
the level of Fas in HeLa was low as previously reported
(Muhlenbeck et al., 1998), the two clones, designated
HeLa/AAV/Fas-1 and -2, overexpressed Fas (Fig. 1B).
These two HeLa/AAV/Fas clones were selected from 24
drug-resistant clones.
In Southern blotting analysis, the AAV DNA in XbaI-
or BglII-digested cellular DNA of HeLa/AAV/Fas-1 and
-2 was indistinguishable in size from that of the pa-
rental HeLa/AAV (Figs. 2B and 2D). Both HeLa/AAV/
Fas clones expressed AAV capsid proteins upon in-
fection with Ad (Fig. 1C), indicating complete AAV DNA
was present in these cells. In HeLa/AAV/Fas, the cy-
topathic effects by Ad emerged slowly and the levels
of AAV capsid proteins were low. The overexpression
of Fas probably influences growth of Ad, due to yet
unknown mechanisms.
Production of AAV virions was induced by anti-Fas
antibody more efficiently in HeLa/AAV/Fas-1 and -2
than in the parental HeLa/AAV (Fig. 3). The depen-
dency on the Fas level indicates that Fas was involved
in the antibody-induced AAV virion production. Approx-
imately 105 to 106 virions or genome copies of encap-
sidated AAV DNA were found to be present in the
extract from 2  105 cells of HeLa/AAV/Fas-1 or -2
stimulated by anti-Fas antibody.
Infectious virions were found in the extract from HeLa/
AAV/Fas-1 stimulated with anti-Fas antibody. The DNase-
digested extract from the cells of 2  104 was inoculated
to each of three wells containing 3  105 cells. Twenty-
four hours later the HeLa cells were superinfected with
Ad (m.o.i. 50) and further incubated for 72 h. The cells in
the each well were harvested, resuspended in 200 l of
PBS, sonicated, and then centrifuged. DNA was ex-
tracted from the supernatant and used for the template of
PCR to amplify AAV DNA (Fig. 4). The extracts from two of
the three wells were positive for the amplified fragment
of AAV DNA. In this experiment, the extract from the three
wells inoculated with purified AAV virions of more than
105 genome copies were positive for the AAV DNA (Fig.
4). One of the three wells was positive when 104 genome
copies were used for the inoculum. Therefore, the extract
from 2  104 cells of HeLa/AAV/Fas-1 stimulated by
anti-Fas antibody was estimated to contain 104 to 105
genome copies of virions. The number of virions is con-
sistent with the number of the encapsidated AAV DNA
copies.
FIG. 3. Encapsidated AAV DNA produced in HeLa/AAV clones by stimulation with anti-Fas antibody. Cells cultured with or without antibodies
(against Fas or FLAG) for 48 h were lysed and digested with DNase I to eliminate free-DNA. Then, encapsidated DNA, which was protected from the
DNase digestion, was extracted and used as the template for the PCR to amplify AAV or G3PDH DNA. PCR products were electrophoresed in a 2%
agarose gel and stained with ethidium bromide. For comparison, purified AAV virions were mixed with a cellular lysate of HeLa cells and processed
similarly. Lines 53 and 107 represent HeLa/AAV clones and Fas-1 and Fas-2 represent HeLa/AAV/Fas clones.
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Apoptotic DNA fragmentation caused by anti-Fas
antibody
Anti-Fas antibody was shown to cause cell DNA frag-
mentation in HeLa/AAV and Fas-enriched HeLa/AAV, by
TUNEL, which is a method to label the 3 end of intracel-
lular fragmented DNA for cytological detection and by aga-
rose gel electrophoresis of extracted DNA. The cells were
cultured in the presence of anti-Fas antibody (100 ng/ml) for
48 h and were then subjected to the two assays. After
TUNEL staining, whereas DNA fragmentation was recog-
nized in approximately 1% of the HeLa/AAV cells, it was
recognized in 20 and 10% of HeLa/AAV/Fas-1 and -2 cells,
respectively (Fig. 5A). These cytological observations were
consistent with the electrophoresis data obtained with the
extracted cellular DNA (Fig. 5B). Presence of fragmented
chromosomal DNA was evident in both HeLa/AAV and
HeLa/AAV/Fas cells, but clearly more prominent in the lat-
ter. The fact that HeLa/AAV/Fas was more sensitive to the
antibody than HeLa/AAV appears to be evidence that the
antibody-induced DNA fragmentation resulting from Fas-
mediated apoptosis. It should be noted that the HeLa/AAV
cells appeared to be significantly more sensitive to induc-
tion of apoptosis by anti-Fas antibody than the parental
HeLa cells.
If we assume only the apoptotic cells recognized by
TUNEL had been producing AAV virions, we could esti-
mate their yield per cell from the data in Figs. 2 and 4A.
In HeLa/AAV/Fas, the yield in 48 h would be approxi-
mately in the range of 50 to 100 virions per TUNEL-
positive cell. The yields calculated for HeLa/AAV-53 and
-107 fell into the lower part of the range. The data sug-
gest that the level of the virion induction is dependent on
the extent of Fas-mediated apoptosis in HeLa cells.
Inhibition of AAV production and cell DNA
fragmentation in Fas-enriched HeLa/AAV
by caspase-8 inhibitor
Caspase-8 inhibitor, z-IETD-fmk (Martin et al., 1998),
was shown to inhibit anti-Fas antibody from inducing
AAV virions and DNA fragmentation in HeLa/AAV/Fas-1.
The cells were cultured in the growth medium containing
the inhibitor (50 M) for 60 min and then further incu-
bated in the medium containing the inhibitor plus anti-
Fas antibody for 48 h. The encapsidated AAV DNA, which
would be induced by the antibody, was not detected in
the extracts from the cells treated with the inhibitor (Fig.
6A). In the presence of the inhibitor, the antibody did not
cause the DNA fragmentation (Fig. 6B). Thus, it was
shown that activation of caspase-8, which triggers the
caspase cascade in Fas-mediated apoptosis, is required
for the DNA fragmentation and the induction of AAV in
HeLa/AAV/Fas, indicating that the antibody induction of
AAV production is indeed associated with the apoptosis.
In summary, we found that AAV can be rescued, albeit
inefficiently, from viral DNA integrated in HeLa chromo-
some by the antibody-induced Fas-apoptosis. The re-
sults of this study support our hypothesis on the AAV’s
ability to escape from the programmed cell death, al-
though it remains to be studied whether the AAV provirus
can be rescued by apoptosis in natural latent infection.
It may be that, when the host cell is going to be
excluded by apoptosis, the AAV provirus initiates repli-
cation without a helper virus. The helper-independent
replication would contribute to survival of AAV in vivo,
since the incidence of helper infection would not be very
high for a cell with the latent AAV at the right time before
cell death. The level of infectious AAV produced in the
apoptotic cells in this study was much lower than that
produced in the cells infected with Ad, suggesting that
cells in the course of apoptosis do not contain enough
cellular or viral factors that can be supplemented by Ad
infection to support efficient AAV replication. Although
the induced AAV level is low in apoptosis, it is probably
sufficient for AAV to escape from the programmed cell
death and infect surrounding cells.
It has been reported that the helper-independent AAV
replication occurs in cells irradiated with UV or pretreat-
ment with genotoxic chemicals (Yakinoglu et al., 1988;
Yakobson et al., 1987). These stresses give damage
directly on DNA at the beginning and the damage in-
duces activation of ATM-kinase and p53, resulting in the
cell growth arrest to repair the DNA damage or activation
of the caspase cascade to kill the injured cells (Meyn,
1995; Banin et al., 1998; Canman et al., 1998). The cellular
mechanisms for DNA repair are believed to be important
for the cells’ helper functions (Berns and Bohenzky, 1987;
Zentilin et al., 2001). However, the DNA repair system is
considered not to be associated with Fas-mediated ap-
optosis. Thus, this is the first report of the helper-inde-
FIG. 4. Infectivity of the rescued AAV from HeLa/AAV/Fas-1 by anti-
Fas antibody. The rescued AAV was inoculated to HeLa cells with or
without Ad. For comparison, purified AAV virions were inoculated to
HeLa similarly. Seventy-two hours later, the infected cells were lysed
and incubated with DNase I. AAV DNA protected from the digestion
was extracted from virions and was amplified by PCR. The amplified
DNA was electrophoresed in a 2% agarose gel and stained with
ethidium bromide.
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pendent AAV replication without activation of DNA repair
mechanism. It would be interesting to study how the
integrated AAV DNA is activated to replicate, using the
molecular events activated by the apoptosis.
MATERIALS AND METHODS
Plasmids
AAV2 complete genome excised from pAV1 (pur-
chased from ATCC, no. ATCC37215) by BglII digestion
was cloned at BglII site which was newly generated
between two PvuII sites of pUC19 by insertion of BglII
linker. The resultant plasmid, pUC19-AAV, was used for
transfection to produce HeLa cells containing AAV DNA
integrated in chromosomes. pSV2-brs was purchased
from Kaken Pharmaceutical Co., Ltd. (Tokyo, Japan).
An expression plasmid for Fas, pCMV-Fas, was con-
structed by insertion of cDNA encoding Fas into pCMV-
Tag4 (Stratagene, La Jolla, CA) at its EcoRI site. The
cDNA for Fas in TG-1 (primary human fibroblast) cDNA
FIG. 5. Apoptotic DNA fragmentation in HeLa/AAV and HeLa/AAV/Fas clones cultured with or without anti-Fas antibody for 48 h. (A) The cells
containing fragmented DNA were detectable by staining the 3 ends of DNA by TUNEL method in the cultures without anti-Fas (top) and in those with
anti-Fas (bottom). (B) Total DNA extracted from the cells was electrophoresed in a 1.2% agarose gel and stained with ethidium bromide. Fragmented
DNA was recognizable as heterogeneous fast moving DNA. Line 53 represents HeLa/AAV clones and Fas-1 and Fas-2 represent HeLa/AAV/Fas
clones.
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library was amplified by PCR using primers of 5-TCAA-
CAACCATGCTGGGCATCTGG and 5-CTAGACCAAGCTT-
TGGATTTC. The nucleotide sequence of the amplified
DNA matched that in the data base (GenBank Accession
No. M67454).
Reagents
Anti-Fas mouse monoclonal antibody (CH-11) used for
stimulation of HeLa/AAV cells and anti-Fas rabbit poly-
clonal antibodies (sc-714) used for immunoblotting were
purchased from MBL Co., Ltd. (Nagoya, Japan) and Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA), respectively.
Anti-FLAG antibody used for attempted stimulation was
purchased from Sigma-Aldrich (St. Louis, MO). Caspase
inhibitor, z-IETD-fmk, which inhibits activity of caspase-8,
was purchased from Calbiochem-Novabiochem (La Jolla,
CA). Restriction enzymes and DNase I was purchased
from Takara Shuzo Co., Ltd. (Kyoto, Japan).
Transfection of DNA to HeLa cells
Cells used in this study were cultured in Dulbecco’s
modified minimal essential medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS) and grown in
5% CO2 at 37°C. Subconfluent culture of the cells in a
10-cm plate was transfected with 2 g of plasmid DNA
using Effectene (Qiagen GmbH, Hilden, Germany). After
incubation for 48 h, the cells were passaged at a split
ratio of 1 to 10 and cultured in the growth medium
containing a selective drug, brasticidin (2 ng/ml) or G418
(500 g/ml). Drug-resistant cell clones were obtained by
three successive single colony isolations.
Immunoblotting
To detect AAV capsid proteins, cells were infected with
adenovirus type 2 (Ad) at an m.o.i. of 50, incubated in
growth medium for 48 to 72 h, suspended in the medium
by a rubber policeman, and incubated at 60°C for 30 min.
The cells were precipitated by a centrifugation of 3000
rpm for 10 min, resuspended in PBS, sonicated briefly,
and centrifuged at 3000 rpm for 10 min. The supernatant
was mixed with an equal volume of 2 SDS sample
buffer (SDS sample buffer: 153 mM Tris–HCl, pH 7.5, 4.9%
SDS, 6.13% 2-mercapt ethanol, 24.5% glycerol, and
0.0025% bromphenol blue) and boiled for 5 min. To detect
Fas, cells were collected by a centrifugation of 3000 rpm
for 10 min, suspended in appropriate volume of SDS
sample buffer, and boiled for 5 min.
The samples were electrophoresed in 10% SDS–PAGE
and the proteins were transferred to nylon membrane,
Hybond-P (Amersham Biosciences Inc., Uppsala, Swe-
den). After blocking with 5% skim milk, VP proteins of AAV
were probed by anti-VP mouse monoclonal antibody
(#65158, Progen GmbH, Heidelberg, Germany), and Fas
was probed by anti-Fas rabbit antiserum, sc-714. Horse-
radish peroxidase conjugated anti-rabbit IgG goat anti-
bodies (SC-2020, Santa Cruz Biotechnology, Inc.) and
ECL Western Blotting Detection System (Amersham Bio-
sciences Inc.) were used to detect mouse anti-AAV-VP or
anti-Fas IgG.
Southern blotting
Cellular DNA was extracted and purified with Qiagen
Genomic-tip system (Qiagen GmbH). Eighteen micro-
grams of DNA was digested with restriction enzymes,
XbaI, HindIII, BamHI, and BglII, electrophoresed on 0.8%
agarose gel, and transferred to a nylon membrane (Hy-
bond-XL, Amersham Biosciences, Inc.). 32P-labeled
probes were prepared by Rediprime II DNA labeling
system (Amersham Biosciences Inc.).
Detection of AAV DNA protected from DNase I
Cells (2  105) in a 35-mm culture plate were incu-
bated in growth medium containing anti-Fas antibody
(100 ng/ml) for 48 h. When effect of caspase-8 inhibitor
was examined, cells were incubated with growth me-
dium containing z-IETD-fmk (50 M) for 60 min, refed
with growth medium containing z-IETD-fmk (50 M) and
anti-Fas antibody (100 ng/ml), and incubated for 48 h.
Since z-IETD-fmk was suspended in dimethyl sulfoxide
FIG. 6. Effect of z-IETD-fmk, a caspase-8 inhibitor, on induction of
encapsidated AAV DNA (A) and apoptotic DNA fragmentation (B) in
HeLa/AAV/Fas-1 (see Materials and Methods for details).
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(DMSO), control cells were incubated with growth me-
dium containing DMSO (0.1%). The cells were scraped off
from the plastic surface by a rubber policeman, collected
by low speed centrifugation, resuspended in 200 l of
PBS containing MgCl2 (10 mM), and then sonicated
briefly. For comparison, normal HeLa cells (2 106) were
mixed with serially diluted purified AAV virions (0 to 107
genome copies) or cloned AAV DNA (pUC19-AAV, 107
genome copies) and sonicated. The sample was diluted
with 800 l of PBS containing MgCl2 (10 mM), mixed with
500 l of diethylether with vortex mixer, and an upper
layer was removed after a centrifugation of 12,000 rpm
for 2 min. The diethylether extraction was done twice and
the sample was centrifuged 10,000 rpm for 10 min. The
supernatant and DNase I (1400 units) were incubated at
37°C overnight and received 50 l of 0.5 M EDTA to stop
digestion with DNase. DNA was extracted from the re-
sultant DNase-digested sample by using QIAamp DNA
extraction kit (Qiagen GmbH). Twenty microliters out of
total 200 l of final DNA sample in TE buffer was used for
PCR to detect AAV DNA.
Titration of infectious AAV in cell extracts
Normal HeLa cells (3  105/well) in 24-well culture
plate were incubated with 100 l of the DNase-digested
sample (described above) prepared from HeLa/AAV/
Fas-1 or from normal HeLa plus purified AAV virions at
37°C for 2 h and further incubated for 24 h after addition
of 1 ml of growth medium. Then, the cells were infected
with Ad (m.o.i. 50) and incubated for 72 h. The cells were
scraped off by a rubber policeman in the medium used
for cultivation and collected by low-speed centrifugation
after incubation at 60°C for 30 min to inactivate Ad. The
cells were resuspended in 200 l of PBS, sonicated
briefly, and centrifuged at 3000 rpm for 10 min. DNA was
extracted from the supernatant using QIAamp DNA ex-
traction kit (Qiagen GmbH). Twenty microliters of total
200 l of final DNA sample in TE buffer was used for PCR
to detect AAV DNA.
PCR
The following primers were used to amplify AAV DNA:
forward primer: 5-GAACTGGGTGGCCGAGAAGG (AAV
nucleotides of 401 to 420, numbering of the nucleotide
are according to AF043303 in GenBank), reverse primer:
5-CTCTGAATCAGTTTTTCGCG (676 to 657). The follow-
ing primers were used to amplify a part of G3PDH gene:
forward primer: 5-ACCACCATGGAGAAGGCTGG, re-
verse primer: 5-GGATGATGTTCTGGAGAGCC. PCR con-
sisted of the initial heating at 94°C for 5 min, followed by
37 or 35 cycles of incubation at 94°C for 30 s and then at
64°C for 2 min, and followed by the final incubation at
72°C for 7 min. Thirty-seven cycles were used for detec-
tion of AAV DNA protected from DNase digestion or
G3PDH DNA (Fig. 2). Thirty-five cycles were used for
titration of infectious AAV (Fig. 5).
Detection of apoptosis
Based on fragmentation of cellular DNA, apoptosis
was detected by TUNEL or agarose gel electrophoresis.
Cells (2  105) in a slide chamber were cultured with
growth medium containing anti-Fas antibody (100 ng/ml)
for 24 h. The fragmented DNA was stained with In situ
cell death detection kit (Roche Diagnostics Co. Ltd.,
Mannheim, Germany).
Cells (1  106) in a 6-cm culture plate were incubated
with growth medium containing anti-Fas antibody (100
ng/ml) for 24 h. Otherwise, cells were incubated with
growth medium containing z-IETD-fmk (50 M) for 60
min, refed with growth medium containing z-IETD-fmk
(50 M) and anti-Fas antibody (100 ng/ml), and then
incubated for 24 h. DNA extracted from the cells using
QIAamp DNA extraction kit (Qiagen GmbH) was exam-
ined for the fragmentation by ApoAlert LM-PCR kit (Clon-
tech Co. Ltd., Palo Alto, CA) and agarose gel (1.2%)
electrophoresis.
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